Search results
Arch, a prolific biotech creator, is raising $3B for startup investing
BioPharma Dive via Yahoo Finance· 4 months agoArch Venture Partners, one of the biotechnology sector’s most prolific company creators, is raising...
Boundless Bio, a Bayer-backed cancer biotech, seeks an IPO
BioPharma Dive via Yahoo Finance· 3 months agoBoundless Bio, an oncology startup backed by Bayer and Arch Venture Partners, on Wednesday became...
Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start...
TechCrunch· 2 months agoAdvances in generative AI have taken the tech world by storm. Biotech investors are making a big bet...
Gene therapy biotech Jaguar spins out manufacturing company
BioPharma Dive via Yahoo Finance· 5 months agoJaguar Gene Therapy is spinning out part of its business to handle the specialized work of...
PureTech launches Seaport, hoping to create Karuna 2.0
BioPharma Dive via Yahoo Finance· 2 months agoHoping to repeat a recent success story, the biotechnology startup creator PureTech Health has...
Jeff Bezos and Bill Gates are making bets on brain interface company Synchron as Elon Musk’s...
Fortune via Yahoo Finance· 2 years agoAs Elon Musk’s frustration with his brain technology startup Neuralink mounts, Jeff Bezos and Bill...
Venture firm Scion Life Sciences launches with $310M to back new biotechs
BioPharma Dive via Yahoo Finance· 4 months agoThe new firm intends to carefully select its startups and fund them for the long haul. “We're not a...
Weight-loss drug developer Metsera raises $290 million in funding
Reuters via Yahoo News· 2 months agoWeight-loss drug developer Metsera has raised $290 million in funding, led by biotech investor ARCH Venture Partners as well as participation from firms such as SoftBank and Mubadala Capital ...
FogPharma pulls in $145M to support cancer drug research
BioPharma Dive via Yahoo Finance· 3 months agoDive Brief: Cancer drug developer FogPharma has raised $145 million in fresh funding, the company...
Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo
BioPharma Dive via Yahoo Finance· 2 months agoIt’s “early innings” in the obesity drug race, said Metsera CEO Clive Meanwell, whose company...